Orgenesis Operating Income

Orgenesis (ORGS) currently reports a operating income of $-93M as of September 2024. That compares with $-8.3M in the prior-year period — down 1011.7% year over year. Use the charts on this page to explore Orgenesis's operating income history and peer comparisons.

Orgenesis's operating income decreased from $-8.3M to $-93M — a 1011.7% year-over-year decrease (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Orgenesis reported $-93M in operating income as of September 2024. That compares with $-8.3M in the prior-year period — down 1011.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-93M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Orgenesis, and consider following ORGS for alerts when major investors trade the stock.

Orgenesis is classified in the Healthcare sector. On operating income, it currently shows $-93M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ORGS with unrelated industries.